An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
Avian influenza: A vaccine for a deadly emergent strain A vaccine candidate to treat a deadly subtype of avian influenza was shown to induce protective antibodies in initial clinical trials. As of March 2017, avian influenza strain A/H7N9 has killed 497 people since 2013, with 1349 confirmed cases....
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e2d2da024d7c4739ac5a7e10fb271246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|